Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 4 Results

Intervention Indication Therapeutic Area Year Actions
Secukinumab for enthesitis-related arthritis and juvenile psoriatic arthritis in children and adolescents from the age of 2 years Secukinumab (Cosentyx; AIN457) Enthesitis-related arthritis , Juvenile psoriatic arthritis Rheumatology 2019 View  |  Download
Secukinumab for hidradenitis suppurativa Secukinumab (Cosentyx; AIN457) Hidradenitis suppurativa (HS) Dermatology 2021 View  |  Download
Secukinumab for moderate to severe plaque psoriasis in children aged 6 to less than 18 years old Secukinumab (Cosentyx; AIN457) Plaque psoriasis Dermatology 2019 View  |  Download
Secukinumab for Non-Radiographic Axial Spondyloarthritis – second or subsequent line Secukinumab (Cosentyx; AIN457) Spondyloarthritis Musculoskeletal System , Rheumatology 2018 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications